Although more detailed mechanistic study on the involvement of ROS regulation and the relationship with pancreatic cancer progression is required, current evidence clearly supports the roles of RPL10 in the regulation of ROS level in the cancer cells. The gene discussed is RPL10; the disease is familial pancreatic carcinoma.